1. Introduction {#sec1}
===============

Neuromyelitis Optica (NMO) is a severe demyelinating autoimmune disease involving the central nervous system. Acute respiratory failure (ARF) due to monophasic NMO is uncommon. We report a case of NMO who developed ARF related to cervical myelitis, which was refractory to pulse dose steroid therapy, but resolved with plasmapheresis.

2. Case Report {#sec2}
==============

A 53-year-old female with a history of NMO with positive NMO-immunoglobulin G (NMO-IgG)/aquaporin-4 antibodies (AQP4-Ab) presented to the emergency department (ED) with complaints of headache, left sided weakness, numbness, and tingling for 3 days. Her medications included prednisone 5 mg daily, escitalopram, amitriptyline, and azathioprine. The patient denied smoking, alcohol, or illicit drug use.

In the ED, she was in mild respiratory distress with oxygen (O~2~) saturation of 85% on room air. Other vital signs were normal. Lung and cardiovascular examination was normal. Neurological examination revealed mild weakness, decreased sensation to light touch, hyperreflexia, and a positive Babinski sign on the left. Laboratory data were normal. ABG revealed a pH of 7.46, pCO~2~ of 37.1, and pO~2~ of 60.6 on O~2~ at 2 liters/minute by nasal cannula. Chest X-ray ([Figure 1](#fig1){ref-type="fig"}) showed hypoinflated lung fields with bibasal atelectasis and elevated hemidiaphragms. The patient was started on O~2~ and intravenous pulse dose steroids and continued on her azathioprine home dose. Over the next few hours, the patient became increasingly dyspneic and hypoxic. Negative inspiratory force was −20 cm H~2~O. A computed tomogram (CT) scan of the chest ([Figure 2](#fig2){ref-type="fig"}) showed bibasilar atelectasis. Lung ultrasound revealed impaired movement of the left diaphragm, consistent with paresis. The patient was started on bilevel positive airway pressure (BIPAP). Cervical spine MRI ([Figure 3](#fig3){ref-type="fig"}) showed increased T2 signal within the spinal cord with heterogeneous enhancement in the cord extending between the mid-C2 and T1 vertebrae.

The patient\'s ARF was felt to be due to cervical cord involvement by NMO, resulting in diaphragmatic weakness. Patient was started on pulsed steroids: methylprednisolone at 1 gram IV daily for 3 days, followed by 1.5 gm/kg/day for 3 days, following which it was rapidly tapered off. Plasmapheresis was started on day 4 after no significant clinical response was seen after 3 days of pulsed steroid therapy. Plasmapheresis was performed daily for 5 days, following which the patient\'s respiratory distress and oxygenation improved and BIPAP was discontinued. Her diaphragmatic excursion normalized on fluoroscopy. Her neurologic symptoms also improved significantly.

3. Discussion {#sec3}
=============

NMO, also known as Devic\'s disease, is a rare but severe inflammatory, demyelinating, and necrotizing autoimmune disease of the central nervous system which is distinct from multiple sclerosis (MS) \[[@B1]\]. It is characterized by recurrent attacks of optic neuritis, myelitis, and presence of NMO-immunoglobulin G (NMO-IgG)/aquaporin-4 antibodies (AQP4-Ab) \[[@B1]\]. The clinical manifestations of NMO are more severe than those of "typical" MS \[[@B1], [@B2]\]. ARF is unknown in MS. Cerebrospinal fluid and MRI findings can distinguish NMO from MS \[[@B3]\].

A revised set of criteria for diagnosis of NMO were proposed in 2006 \[[@B1]\]. These guidelines require two definite criteria: (i) optic neuritis and (ii) acute myelitis plus at least two of three supportive criteria: (i) contiguous spinal cord MRI lesion extending over 3 vertebral segments, (ii) brain MRI not meeting criteria for multiple sclerosis, and (iii) NMO-IgG seropositive status.

Spinal cord involvement in NMO usually presents as transverse myelitis with paraparesis or quadriparesis, a sensory level and sphincter dysfunction \[[@B4], [@B5]\]. NMO may also present as radicular pain, paroxysmal tonic spasms, nausea, and intractable hiccups \[[@B4]\]. Due to involvement of the respiratory center in the medulla, neurogenic ARF and death can occur \[[@B2], [@B3]\].

In one series \[[@B6]\], respiratory dysfunction was reported in 22% patients after onset of NMO. In 16% of these patients, respiratory failure was related to a relapse; 7% required invasive mechanical ventilation. In another series \[[@B4]\], ARF caused by acute cervical myelitis occurred 19 times (33%) in 16 relapsing patients and was responsible for death in 15 (93%) of these patient. Only two patients with monophasic NMO (2%) had this complication, with both patients recovering \[[@B3]\].

The guidelines regarding management are based on expert opinions \[[@B2], [@B4]\]. In one series \[[@B4]\], corticosteroids resulted in improvement in 80% of patients. Plasmapheresis resulted in improvement in 2/3rd of steroid-refractory patients. Majority of patients with acute NMO respond within 1--5 days of high dose intravenous methylprednisolone 1 gram daily for 3--5 consecutive days, followed by slow taper \[[@B2], [@B4]\]. Plasmapheresis and/or intravenous immunoglobulins are used in steroid-refractory cases \[[@B7]\]. Diaphragmatic pacing has also been reported to successfully wean patient with ARF due to NMO requiring mechanical ventilation \[[@B8]\].

In contrast to MS, maintenance therapy with immunosuppressives rather than immunomodulators achieves better prevention of recurrences \[[@B9]\]. Azathioprine, low dose prednisolone, or rituximab may be used for maintenance \[[@B10]\]. Methotrexate, cyclophosphamide, mycophenolate, and mitoxantrone have been used with variable success \[[@B4], [@B9]\].

The patient was subsequently started on rituximab. On subsequent outpatient follow-up, resolution of her neurologic symptoms was noted.
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